Report #2881009

Received Jan 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Seizure

Symptom narrative

I had a Seizure; This serious case was reported by a consumer via interactive digital media and described the occurrence of seizure in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced seizure (Verbatim: I had a Seizure) (serious criteria GSK medically significant). The outcome of the seizure was not reported. It was unknown if the reporter considered the seizure to be related to Shingrix. The company considered the seizure to be unrelated to Shingrix. Additional Information: GSK receipt date 05-JAN-2026 The case was received from the consumer via interactive digital media. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Seizure, an unknown time after receiving Shingrix, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.